Health ❯ Pharmaceuticals

Drug Discovery

Therapeutics Antibiotics Quantum Applications Clinical Trials Bioactive Compounds Research and Development AI in Drug Development Therapeutics Development Antimicrobial Agents Molecular Interactions

Lilly Strikes $2.75 Billion Deal to Commercialize Insilico’s AI-Designed Drugs

The pact signals big pharma’s push to tap outside AI tools for faster pipelines.

Nvidia, Eli Lilly Commit Up to $1 Billion for Bay Area AI Drug Discovery Lab

Insilico and Servier Strike Up to $888 Million AI-Oncology Partnership

Abzena, Mabqi Forge Partnership to Link Antibody Discovery With Development and GMP Manufacturing

IonQ Claims 99.99% Two-Qubit Gate Fidelity in New Papers, Sending Shares Higher

Molecular 'Magnifying Glass' Flags Early Protein Aggregation in Living Cells

2025 Lasker-DeBakey Award Honors Scientists Behind Trikafta’s Cystic Fibrosis Breakthrough

Raina Biosciences’ Science Paper Showcases AI-Designed mRNA With Higher Expression and Stability

Emory Revamps Chan–Evans–Lam Reaction to Expand Access to Vinylic Ethers

Peer-Reviewed OU Study Maps Amylin Receptors, Offering Tools for Next‑Gen Obesity Drugs

AI Identifies Thousands of Potential Antibiotics in Archaea

Cryo-EM Reveals LptM’s Key Role in Stabilizing Bacterial LptDE Complex

Spinncloud Wins Million-Euro Order for Europe’s Largest Brain-Inspired Supercomputer

Minor Splicing Inhibition Yields Drug Leads for KRAS-Driven Cancers

Denmark’s QuNorth Secures €80 Million to Build Magne Quantum Computer

Wockhardt Liquidates US Generics Units to Fuel Antibiotic and Insulin Innovation

Microsoft Unveils BioEmu 1.1 to Slash Protein Simulations to GPU-Hours

Nvidia Partners with Swedish Consortium to Build Country’s Biggest Enterprise AI Supercomputer

Researchers Identify Broad-Spectrum Inhibitors for Malaria Parasite's Key Protein Family

Google DeepMind Spinoff Plans AI-Designed Drug Trials by Year-End